project id: TCGA-PAAD; case submitter id: TCGA-IB-A5SP; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.11; rna integrity number: 7.4; age at index: 77; days to birth: -28317; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1934; age at diagnosis: 28317; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 482.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 397; days to sample procurement: 0; initial weight: 240.0; portion submitter id: TCGA-IB-A5SP-01A-11; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 2.0; percent necrosis: 4.0; percent neutrophil infiltration: 2.0; percent normal cells: 2.0; percent stromal cells: 59.0; percent tumor cells: 35.0; percent tumor nuclei: 75.0;